ACTIM 2.5mg Tablets
ACTIM 5mg Tablets
ONATO-V HCT 5mg/160mg/25mg Tablets
ABACUS 40mg/5ml Suspension
AZITMA 250mg Tablets
AZITMA 500mg Tablets
AZITMA 200mg/5ml Suspension
AZITMA 500mg Injection
CARICEF 400mg Capsules
CARICEF Suspension 100mg/5ml
CARICEF DS Suspension 200mg/5ml
CYNFO 250mg/5ml Suspension
ECASIL 200mg/100ml Infusion
ECASIL 600mg/300ml Infusion
GRASIL 25mg Injection
GRASIL 100mg Injection
MOFEST 400mg Infusion
NEUCEF Paediatric 100mg/ml Drops
OTID 125mg/5ml Suspension
RITHMO 250mg/5ml Suspension
RITHMO 125mg/5ml Drops
RENOVA 320mg Tablets
SLATE 50mg/ml Drops
ALKERIS 1.5% w/w Cream
SAMI Pharmaceuticals (Pvt.) Ltd, Pakistan is an established pharmaceutical manufacturer producing, since 1976, drugs of standard quality with full compliance of cGMP. With an annual turnover of US$ 220 million, SAMI is currently ranked as the 2nd largest pharmaceutical manufacturer of the Country (Source: IQVIA). Some of SAMI's brands as Novidat (Ciprofloxacin), Oxidil (Ceftriaxone), Grasil (Amikacin), 2SUM (Cefoperazone + Sulbactam), Ecasil (Linezolid), Timequin (Dihydroartemisinin + Piperaquin), Rolac (Itraconazole), Nims (Nimesulide), Movax (Tizanidine), Provas Infusion (Paracetamol Infusion 1g/100ml), Tercica (Dexibuprofen), Tonoflex-P (Tramadol + Paracetamol), Kinz (Nalbuphine), Breeky (Misoprostol), Trimetabol (Appetite Stimulant) and Lacasil (Lactitol) enjoy leadership and dominance in important therapeutic areas like anti infectives, rheumatology, narcotic analgesics, etc. SAMI follows aggressive ethical marketing through a large professional, experienced and motivated marketing team. SAMI enjoys technical collaboration and licensing arrangements with renowned European pharmaceutical manufacturers. Recently SAMI has introduced Provas Duo (Paracetamol 500mg + Ibuprofen 200mg) Tablets, which have received overwhelming response from the medical community. We have 6 other oral variants of Paracetamol to be introduced in the market soon; details can be found in the enclosed Product portfolio. SAMI has recently developed a state of the art fill-finish facility for Recombinant Proteins and Vaccines to be produced in liquid and lyophilized forms, packed in ampoules, vials and PFS from respective bulk concentrates to be imported from competent sources. This facility has been developed based on the latest guidelines of international regulatory bodies. We have a vast range of products in various dosage forms; solid, liquid, parenteral and topical. We have an extensive variety of products in anti-infective, NSAIDs and anti-ulcerant therapeutic classes. We are ranked no.1 in the market share of anti-infectives in Pakistan. Among parenteral preparations, SAMI Pharmaceuticals is ranked no.1 among all the multinational and the national corporates. We are currently exporting our finished products to different countries. Moreover, we have been doing contract manufacturing and also involved in technology transfer of finished pharmaceutical products.
- Vast range of pharmaceutical products in various dosage forms; solid
- liquid
- parenteral and topical